In an advance, online publication of Nucleic Acids Research this week, an international research team describes a novel role for miR-382, which they've uncovered using miRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1. "Knockdown of miR-382, which was upregulated by TGFβ1, attenuated TGFβ1-induced loss of the epithelial marker E-cadherin," while "knockdown of miR-382 attenuated TGFβ1-induced downregulation of SOD2," the authors write.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.